ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $601,001 | -33.8% | 5,050 | -0.9% | 0.01% | -28.6% |
| Q2 2023 | $908,235 | +7.0% | 5,097 | -1.0% | 0.01% | 0.0% |
| Q1 2023 | $849,214 | +7.3% | 5,148 | +2.4% | 0.01% | 0.0% |
| Q4 2022 | $791,652 | +22.5% | 5,027 | +17.3% | 0.01% | +16.7% |
| Q3 2022 | $646,000 | +75.1% | 4,285 | +91.2% | 0.01% | +100.0% |
| Q2 2022 | $369,000 | -6.8% | 2,241 | +26.0% | 0.00% | +50.0% |
| Q1 2022 | $396,000 | +46.1% | 1,778 | +34.8% | 0.00% | 0.0% |
| Q1 2021 | $271,000 | -19.1% | 1,319 | -15.7% | 0.00% | 0.0% |
| Q4 2020 | $335,000 | -40.0% | 1,564 | -48.7% | 0.00% | -50.0% |
| Q3 2020 | $558,000 | +30.4% | 3,051 | +31.5% | 0.00% | +33.3% |
| Q2 2020 | $428,000 | -19.1% | 2,320 | -11.5% | 0.00% | -40.0% |
| Q1 2020 | $529,000 | -19.5% | 2,620 | -25.4% | 0.01% | 0.0% |
| Q4 2019 | $657,000 | +76.1% | 3,513 | +50.2% | 0.01% | +66.7% |
| Q3 2019 | $373,000 | +24.3% | 2,339 | +96.7% | 0.00% | +50.0% |
| Q2 2019 | $300,000 | -60.3% | 1,189 | -62.3% | 0.00% | -66.7% |
| Q1 2019 | $755,000 | -47.7% | 3,155 | -49.8% | 0.01% | -50.0% |
| Q4 2018 | $1,444,000 | -33.9% | 6,287 | -18.6% | 0.01% | -14.3% |
| Q3 2018 | $2,183,000 | -15.3% | 7,719 | -12.1% | 0.01% | -17.6% |
| Q2 2018 | $2,578,000 | -79.7% | 8,778 | -82.6% | 0.02% | -45.2% |
| Q1 2018 | $12,714,000 | +168.8% | 50,364 | +130.0% | 0.03% | +181.8% |
| Q4 2017 | $4,730,000 | +169.7% | 21,896 | +131.9% | 0.01% | +175.0% |
| Q3 2017 | $1,754,000 | +2.3% | 9,441 | -5.0% | 0.00% | -20.0% |
| Q2 2017 | $1,714,000 | +11.8% | 9,934 | -1.0% | 0.01% | +25.0% |
| Q1 2017 | $1,533,000 | -5.3% | 10,039 | -8.6% | 0.00% | -20.0% |
| Q4 2016 | $1,618,000 | +15.5% | 10,983 | -0.8% | 0.01% | +25.0% |
| Q3 2016 | $1,401,000 | -36.5% | 11,077 | -43.4% | 0.00% | -42.9% |
| Q2 2016 | $2,206,000 | +4.8% | 19,564 | -3.2% | 0.01% | 0.0% |
| Q1 2016 | $2,104,000 | -15.1% | 20,216 | -8.0% | 0.01% | 0.0% |
| Q4 2015 | $2,478,000 | +2.5% | 21,975 | -0.5% | 0.01% | 0.0% |
| Q3 2015 | $2,418,000 | -17.3% | 22,086 | -27.7% | 0.01% | 0.0% |
| Q2 2015 | $2,924,000 | -3.9% | 30,559 | -6.5% | 0.01% | 0.0% |
| Q1 2015 | $3,044,000 | +3.0% | 32,674 | -9.4% | 0.01% | 0.0% |
| Q4 2014 | $2,956,000 | +84.4% | 36,080 | +44.5% | 0.01% | +75.0% |
| Q3 2014 | $1,603,000 | +394.8% | 24,972 | +369.2% | 0.00% | +300.0% |
| Q2 2014 | $324,000 | -12.2% | 5,322 | -13.6% | 0.00% | 0.0% |
| Q1 2014 | $369,000 | -10.7% | 6,158 | -5.1% | 0.00% | 0.0% |
| Q4 2013 | $413,000 | -53.8% | 6,490 | -50.7% | 0.00% | -66.7% |
| Q3 2013 | $894,000 | +14.8% | 13,156 | +21.6% | 0.00% | 0.0% |
| Q2 2013 | $779,000 | – | 10,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |